Garmin announces a new reason to get your heart set on a Venu 2 Plus
Credit: Jimmy Westenberg / Android Authority
Garmin announced a new clinically-tested ECG app with FDA approval.
The app will be available on the Garmin Venu 2 Plus to users in the US.
With on-the-spot ECG recording capabilities, the app will help users check for signs of atrial fibrillation (aFib).

Garmin is after users’ hearts with a new, clinically-validated ECG app arriving today on the brand’s top smartwatch. The FDA-approved tool aims to help users more closely monitor their health, utilizing existing sensors on the Garmin Venu 2 Plus to record the electric signals produced by users’ hearts.


Leave a Reply

Your email address will not be published.